Takeda Pharmaceutical Company (TKDA) Revenue
Takeda Pharmaceutical Company Revenue
Takeda Pharmaceutical Company had a revenue of 1.19T in the quarter ending Sep 30, 2026, with -2.69%. This bring the company's revenue in the last twelve months to 4.73T, Increased 1.59%. In the fiscal year ending Mar 31, 2026, Takeda Pharmaceutical Company had annual revenue of 4.78T with 4.28% growth.
- Revenue (ttm)
- 4.73T
- Revenue Growth
- -4.28%
- P/S Ratio
- 0.01
- Revenue/Employee
- EUR 101,585,198
- Employees
- 47,029
- Market Cap
- EUR 60.13B
Revenue Chart
Takeda Pharmaceutical Company Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 4.78T | 195.90B | 4.28% |
| Mar 31, 2025 | 4.58T | 317.79B | 7.45% |
| Mar 31, 2024 | 4.26T | 236.28B | 5.87% |
| Mar 31, 2023 | 4.03T | 458.47B | 12.85% |
| Mar 31, 2022 | 3.57T | 371.19B | 11.61% |
| Mar 31, 2021 | 3.20T | -93.38B | -2.84% |
| Mar 31, 2020 | 3.29T | 1.19T | 56.93% |
| Mar 31, 2019 | 2.10T | 326.69B | 18.45% |
| Mar 31, 2018 | 1.77T | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.